Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 2
2009 3
2010 2
2011 1
2012 2
2013 1
2014 2
2015 6
2016 6
2017 5
2018 5
2019 5
2020 4
2021 5
2022 3
2023 6
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, Cisneros JM, Dolores Navarro M, Fätkenheuer G, Jung N, Rieg S, Lepeule R, Coutte L, Bernard L, Lemaignen A, Kösters K, MacKenzie CR, Soriano A, Hagel S, Fantin B, Lafaurie M, Talarmin JP, Dinh A, Guimard T, Boutoille D, Welte T, Reuter S, Kluytmans J, Martin ML, Forestier E, Stocker H, Vitrat V, Tattevin P, Rommerskirchen A, Noret M, Adams A, Kern WV, Hellmich M, Seifert H; SABATO study group. Kaasch AJ, et al. Among authors: talarmin jp. Lancet Infect Dis. 2024 May;24(5):523-534. doi: 10.1016/S1473-3099(23)00756-9. Epub 2024 Jan 17. Lancet Infect Dis. 2024. PMID: 38244557 Clinical Trial.
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M; MONALISA study group. Charlier C, et al. Lancet Infect Dis. 2017 May;17(5):510-519. doi: 10.1016/S1473-3099(16)30521-7. Epub 2017 Jan 28. Lancet Infect Dis. 2017. PMID: 28139432 Free article.
Answer to May 2019 Photo Quiz.
Talarmin JP, Yera H, Chrétien F, Jouvion G, Plantin P, Siohan P, Hutin P. Talarmin JP, et al. J Clin Microbiol. 2019 Apr 26;57(5):e00089-18. doi: 10.1128/JCM.00089-18. Print 2019 May. J Clin Microbiol. 2019. PMID: 31028228 Free PMC article. No abstract available.
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.
Hervochon C, Hennart B, Leroy AG, Corvec S, Boutoille D, Senneville É, Sotto A, Illes G, Chavanet P, Dubée V, Bleibtreu A, De Carné MC, Talarmin JP, Revest M, Castan B, Bellouard R, Dailly É, Allorge D, Dinh A, Le Turnier P, Gregoire M; Dalbavancin Pharmacokinetics (DALBAP) study group. Hervochon C, et al. Among authors: talarmin jp. J Antimicrob Chemother. 2023 Dec 1;78(12):2919-2925. doi: 10.1093/jac/dkad331. J Antimicrob Chemother. 2023. PMID: 37864551
Elizabethkingia anophelis outbreak in France.
Guerpillon B, Fangous MS, Le Breton E, Artus M, le Gall F, Khatchatourian L, Talarmin JP, Plesiat P, Jeannot K, Saidani N, Rolland-Jacob G. Guerpillon B, et al. Among authors: talarmin jp. Infect Dis Now. 2022 Aug;52(5):299-303. doi: 10.1016/j.idnow.2022.05.005. Epub 2022 May 26. Infect Dis Now. 2022. PMID: 35643388
Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial.
Tran KC, Asfar P, Cheng M, Demiselle J, Singer J, Lee T, Sweet D, Boyd J, Walley K, Haljan G, Sharif O, Geri G, Auchabie J, Quenot JP, Lee TC, Tsang J, Meziani F, Lamontagne F, Dubee V, Lasocki S, Ovakim D, Wood G, Turgeon A, Cohen Y, Lebas E, Goudelin M, Forrest D, Teale A, Mira JP, Fowler R, Daneman N, Adhikari NKJ, Gousseff M, Leroy P, Plantefeve G, Rispal P, Courtois R, Winston B, Reynolds S, Birks P, Bienvenu B, Tadie JM, Talarmin JP, Ansart S, Russell JA; ARBs CORONA II Team. Tran KC, et al. Among authors: talarmin jp. Clin Infect Dis. 2024 Sep 26;79(3):615-625. doi: 10.1093/cid/ciae306. Clin Infect Dis. 2024. PMID: 39325643 Free PMC article. Clinical Trial.
Non-HACEK gram-negative bacilli endocarditis: a multicentre retrospective case-control study.
Sebillotte M, Boutoille D, Declerck C, Talarmin JP, Lemaignen A, Piau C, Revest M, Tattevin P, Gousseff M; Groupe d‘Epidémiologie et Recherche en Infectiologie Clinique du Centre et de l’Ouest (GERICCO). Sebillotte M, et al. Among authors: talarmin jp. Infect Dis (Lond). 2023 Sep;55(9):599-606. doi: 10.1080/23744235.2023.2226212. Epub 2023 Jun 24. Infect Dis (Lond). 2023. PMID: 37353977 Free article.
Chronic meningococcemia: a report of 26 cases and literature review.
Lefèvre B, Poinsignon Y, Piau C, Javaugue FC, Talarmin JP, Lefebvre M, Varache N, Drouin H, Tattevin P; pour le Groupe d’Epidémiologie et Recherche en Infectiologie Clinique du Centre et de l’Ouest (GERICCO). Lefèvre B, et al. Among authors: talarmin jp. Infection. 2019 Apr;47(2):285-288. doi: 10.1007/s15010-018-1238-x. Epub 2018 Oct 19. Infection. 2019. PMID: 30341638 Review.
Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Lafaurie M, Chevret S, Fontaine JP, Mongiat-Artus P, de Lastours V, Escaut L, Jaureguiberry S, Bernard L, Bruyere F, Gatey C, Abgrall S, Ferreyra M, Aumaitre H, Aparicio C, Garrait V, Meyssonnier V, Bourgarit-Durand A, Chabrol A, Piet E, Talarmin JP, Morrier M, Canoui E, Charlier C, Etienne M, Pacanowski J, Grall N, Desseaux K, Empana-Barat F, Madeleine I, Bercot B, Molina JM, Lefort A; PROSTASHORT Study Group. Lafaurie M, et al. Among authors: talarmin jp. Clin Infect Dis. 2023 Jun 16;76(12):2154-2162. doi: 10.1093/cid/ciad070. Clin Infect Dis. 2023. PMID: 36785526 Clinical Trial.
61 results